葛兰素史克ESG报告

1、GSKdeliversstrongQ3performanceandupgrades2025guidanceSpecialtyMedicines,VaccinesandGeneralMedicinesdrivesales,profitande。

2、InvestorRelationsQ32025results1ConfidentialConferencecallandwebcastforinvestorsandanalystsConferencecallandwebcastforinv。

3、Pipelineassetsandclinicaltrialsappendi,Q32025Infectiousdisease2ContentsInnovation,PipelinegrowthClinicaltrialsRespirator。

4、Q32025ResultsQ32025ResultsConferencecallandwebcastforinvestorsandanalystsConferencecallandwebcastforinvestorsandanalysts。

5、Pipelineassetsandclinicaltrialsappendi,Q22025Infectiousdisease2ContentsInnovation,PipelinegrowthClinicaltrialsRespirator。

6、InvestorRelationsQ22025resultspresentationPage1of27Wednesday,Wednesday,3300JulyJuly20220255at1at122,00,00BSTBSTIntroduct。

7、GSKdeliverscontinuedstrongperformanceStrongSpecialtyMedicinesperformancedrivessalesandcoreoperatingprofitgrowthTotalQ220。

8、AsfiledwiththeSecuritiesandE,changeCommissiononMarch3,2025UNITEDSTATESSECURITIESANDE,CHANGECOMMISSIONWashington,D,C,2054。

9、1InsidethisreportStrategicreport1AheadTogether2Businessmodel42024performanceandkeyperformanceindicators6Chairsstatement8。

10、GSKmakesstrongstartto2025withgrowthinsales,profitsandearningsSpecialtyMedicinesgrowthdrivesQ1performanceTotalQ1sales7,5b。

11、InvestorRelationsQ12025resultspresentation1Introduction,ConstantinFestSlide1,Q12025ResultsSlide2,AgendaLadiesandgentleme。

12、Pipelineassetsandclinicaltrialsappendi,Q12025Infectiousdisease2ContentsInnovation,PipelinegrowthClinicaltrialsRespirator。

13、1GSKResponsibleBusinessPerformanceReport2024March2025ResponsibleBusinessPerformanceReport20242GSKResponsibleBusinessPerf。

14、1March2025GSKreportagainstthefollowingmetricsforallsitesunderoperationalcontrolasdefinedinourorganisationalboundaryappro。

15、1March2025BasisofReportingSocialGovernance2024TableofContentsBasisofReporting2GovernanceofChangestoPublishedData2DataMan。

16、AtGSK,weunitescience,technologyandtalenttogetaheadofdiseasetogether,Weaimtopositivelyimpactthehealthof2,5billionpeopleby。

17、AnnualReport2022GSKAnnualReport2022StrategicreportAheadTogether012022performanceandkeyperformanceindicators02Chairsstate。

18、强劲的增长前景卓越的品类领先品牌组合,具有吸引人的全球布局和竞争能力,在一个不断增长的1,500亿以上的行业中表现出色的战略,这比以往任何时候都更重要,中期46的年度有机销售增长,可持续的适度利润率扩张和高现金转换具有投资能力和交付股东回报。

19、ESGPerformanceReport2021March2022Inthisreport,OurTrustpriority1Progressin2021Scienceandtechnology2Affordabilityandavaila。

20、AnnualReport2020ContentsStrategicreportOurbusinessmodel01Chairmansstatement03CEOsstatement04Financialperformance06Ourlon。

21、AnnualReport2019ContentsStrategicreportOurbusinessmodel01Chairmansstatement03CEOsstatement04Financialperformance06Ourlon。

22、AnnualReport2018ContentsGSKAnnualReport2018StrategicreportGSKataglance01Chairmansstatement02CEOsstatement03Financialperf。

23、AnnualReport2017ImageHIVvirusGSKAnnualReport2017Coverimage30yearsafterdevelopingthefirstHIVmedicine,ourresearchintotreat。

24、AnnualReport20162016sawgoodsalesmomentumacrossPharmaceuticals,VaccinesandConsumerHealthcareandfurtherpipelineprogressCau。

25、AnnualReport20152015sawsubstantialprogresstoacceleratenewproductsalesgrowthandstrengthenourPharmaceuticals,VaccinesandCo。

26、AnnualReport2014,Iamproudtoworkonourrespiratoryportfolioandknowhowimportantthesemedicinesaretothelivesofpatients,Julie,G。

27、AnnualReport2013,Beingactiveandhavingapositiveoutlookonlifeiswhatkeepsmegoingeveryday,Pleasegotopage4formoreMoreatCautio。

28、AnnualReport2012Domore,feelbetter,livelongerbGSKAnnualReport2012AchildbeingseenbyadoctorworkingforBrazilsunifiedhealthsy。

29、2011Domore,feelbetter,livelongerAnnualReportforshareholdersOurBoard78OurCorporateE,ecutiveTeam80Governanceandpolicy84Sha。

30、Gla,oSmithKlineAnnualReport2010Domore,feelbetter,livelongerGSKAnnualReport2010Businessreview2010Performanceoverview08Res。

31、GSKischangingAnnualReport2009Domore,feelbetter,livelongerHeadOfficeandRegisteredOfficeGla,oSmithKlineplc980GreatWestRoad。

32、AnnualReport2008GrowDeliverSimplifyDomore,feelbetter,livelongerFindoutmoreaboutGSKWebsiteGla,oSmithKlineswebsitegivesadd。

33、AnsweringtheQuestionsthatmAtterAnnualReport2007WebsiteGla,oSmithKlineswebsitegivesadditionalinformationontheGroup,Inform。

34、AhumanraceAnnualReport2006Domore,feelbetter,livelongerFinancialsummary,CER,growthisonanIFRSbasisfor2006and2005andaUKGAAP。

35、AnnualReport2005Domore,feelbetter,livelongerhumanbeingDomore,feelbetter,livelongerAboutusOurproductsYourhealthResponsibi。

36、Domore,feelbetter,livelongerNewchallengesNewthinkingAnnualReport2004Gla,oSmithKlineplcisanEnglishpubliclimitedcompany,It。

37、1Annualreview2003Gla,oSmithKlineAnnualReportDomore,feelbetter,livelongereverydayImprovingperformanceANNUALREPORT2003Gla。

38、TheImpactofMedicinesAnnualReport2002Domore,feelbetter,liveGla,oSmithKlineplcisanEnglishpubliclimitedcompany,Itssharesare。

39、Connecting,AnnualReport2001Gla,oSmithKlineplcisanEnglishpubliclimitedcompany,ItssharesarelistedontheLondonStockE,changea。

40、Gla,oSmithKline01Gla,oSmithKlineplcAnnualReportfortheyearended31stDecember2000ContentsReportoftheDirectors02Financialsum。